Skip to main content

Advertisement

Log in

Tissue inhibitors of metalloproteinase-expressing cells in human anterior pituitary and pituitary adenoma

  • Original Paper
  • Published:
Medical Molecular Morphology Aims and scope Submit manuscript

Abstract

Extracellular matrix (ECM) is essential in tissue physiology and pathologic conditions such as tumorigenesis. It affects tumor cell behavior, proliferation, and metastasis. Pituitary adenomas differ in their clinical characteristics, including ECM deposition, and we recently reported that the characteristics of collagen-producing cells differed between control human anterior pituitary gland and pituitary adenomas. ECM deposition is not defined solely by production; degradation and maintenance are also important. Tissue inhibitors of metalloproteinases (TIMPs) help maintain ECM by inhibiting degradation caused by matrix metalloproteases. The present study attempted to characterize TIMP-expressing cells in the human anterior pituitary. Specimens of human pituitary adenomas and control pituitary were obtained during surgery, and in situ hybridization for TIMP1, TIMP2, TIMP3, and TIMP4, followed by immunohistochemistry, was used to characterize TIMP-expressing cells. TIMP expression exhibited a distinct pattern in the human anterior pituitary. Azan staining showed that fibrous matrix deposition varied among pituitary adenomas and that the area of fibrosis was associated with the number and number of types of TIMP3-expressing cells. These results suggest that TIMPs are important in the maintenance of ECM in human pituitary and that TIMP expressions are altered in fibrosis associated with pituitary adenoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Evans JJ, Chitcholtan K (2011) Extracellular matrix proteins in the anterior pituitary gland. Open Neuroendocr J 4:111–119

    Article  CAS  Google Scholar 

  2. Paez-Pereda M, Kuchenbauer F, Arzt E, Stalla GK (2005) Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix. Braz J Med. Biol Res 38:1487–1494

    Article  CAS  PubMed  Google Scholar 

  3. McNicol AM (2000) Tumors of the pituitary gland. In: Fletcher CDM (ed) Diagnostic histopathology of tumors. Churchill Livingstone, New York, pp 691–703

    Google Scholar 

  4. Soji T, Herbert DC (1989) Intercellular communication between rat anterior pituitary cells. Anat Rec 224:523–533

    Article  CAS  PubMed  Google Scholar 

  5. Fujiwara K, Jindatip D, Kikuchi M, Yashiro T (2010) In situ hybridization reveals that type I and III collagens are produced by pericytes in the anterior pituitary gland of rats. Cell Tissue Res 342:491–495

    Article  CAS  PubMed  Google Scholar 

  6. Tofrizal A, Fujiwara K, Yashiro T, Yamada S (2016) Alterations of collagens producing cells in human pituitary adenomas. Med Mol Morphol 49:224–232

    Article  CAS  PubMed  Google Scholar 

  7. Visse R, Nagase H (2003) Matrix metalloproteases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–839

    Article  CAS  PubMed  Google Scholar 

  8. Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374–17378

    CAS  PubMed  Google Scholar 

  9. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271:30375–30380

    Article  CAS  PubMed  Google Scholar 

  10. Azuma M, Tofrizal A, Maliza R, Batchuluun K, Ramadhani D, Syaidah R, Tsukada T, Fujiwara K, Kikuchi M, Horiguchi K, Yashiro T (2015) Maintenance of the extracellular matrix in rat anterior pituitary gland: identification of cell expressing tissue inhibitors of matrix metalloproteinases. Acta Histochem Cytochem 48:185–192

    Article  PubMed  PubMed Central  Google Scholar 

  11. Vannucci L (2015) Stroma as an active player in the development of the tumor microenvironment. Cancer Microenviron 8:159–166

    Article  CAS  PubMed  Google Scholar 

  12. Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N (2014) Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. J Neurosurg 121:1462–1473

    Article  PubMed  Google Scholar 

  13. Tomita T (1998) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in pituitary adenomas: possible markers of neuroendocrine cells. Endocr Pathol 8:305–313

    Article  Google Scholar 

  14. Wang H, Li WS, Shi DJ, Ye ZP, Tai F, He HY, Liang CF, Gong J, Guo Y (2008) Correlation of MMP(1) and TIMP(1) expression with pituitary adenoma fibrosis. J Neurooncol 90:151–156

    Article  CAS  PubMed  Google Scholar 

  15. Fujiwara K, Davaadash B, Yatabe M, Kikuchi M, Horiguchi K, Kusumoto K, Kouki T, Yashiro T (2008) Reduction of retinaldehyde dehydrogenase 1expression and production in estrogen-induced prolactinoma of rat. Med Mol Morphol 41:126–131

    Article  CAS  PubMed  Google Scholar 

  16. Pellegrini I, Barlier A, Gunz G, Figarela-Branger D, Enjalbert A, Grisoli F, Jacquet P (1994) Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 79:189–196

    CAS  PubMed  Google Scholar 

  17. Schrimpf C, Xin C, Campanholle G, Gill SE, Stallcup W, Lin SL, Davis GE, Gharib SA, Humphreys BD, Duffield JS (2012) Pericytes TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 23:868–883

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Cid S, Eiro N, Gonzalez LO, Beridze N, Vasquez J, Visozo FJ (2016) Expression and clinical significance of metalloproteinases and their inhibitors by endothelial cells from invasive breast carcinomas. Clin Breast cancer 16:e83–e91

    Article  CAS  PubMed  Google Scholar 

  19. Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW (2002) Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 115:39–50

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Mc Anulty RJ (2007) Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol 39:666–671

    Article  CAS  Google Scholar 

  21. Leivonen SK, Lazaridis K, Decock J, Edwards DR, Kähäri VM (2013) TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblast involves complex interplay between Smad3, p38a, and ERK1/2. PLoS ONE 8:e57474

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Mack M, Yanagita M (2015) Origin of myofibroblast and cellular events triggering fibrosis. Kidney Int 87:297–307

    Article  PubMed  Google Scholar 

  23. Matilla L, Airola K, Ahonen M, Hietarinta M, Black C, Saarialho-kere U, Kähäri VM (1998) Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol 110:416–421

    Article  Google Scholar 

  24. Abbass SAA, Asa SL, Ezzat S (1997) Altered expression of fibroblast growth factor receptors in human pituitary adenomas. J Clin Endocrinol Metab 82:1160–1166

    Article  CAS  PubMed  Google Scholar 

  25. Jiang Y, Goldberg ID, Shi YE (2002) complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21:2245–2252

    Article  CAS  PubMed  Google Scholar 

  26. Ahonen M, baker AH, Kähäri VM (1998) Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invaion and induces apoptosis in melanoma cells. Cancer Res 58:2310–2315

    CAS  PubMed  Google Scholar 

  27. Guedez L, Mcmarlin AJ, Kingma DW, Bennett TA, Stetler-Stevenson M, Stetler-Stevenson WG (2001) Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt’s lymphoma via divergent effects on tumor growth and angiogenesis. Am J Pathol 158:1207–1215

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Ilmiawati C, Horiguchi K, Fujiwara K, Yashiro T (2012) Matrix metalloproteinase-9 expression in folliculostellate cells of rat anterior pituitary gland. J Endocrinol 212:363–370

    Article  CAS  PubMed  Google Scholar 

  29. Paez Pereda M, Ledda MF, Goldberg V, Chervin A, Carizzo G, Molina H, Muller A, Renner U, Podhajcer O, Arzt E, Stalla GK (2000) J Clin Endocrinol Metab 85:263–269

    CAS  PubMed  Google Scholar 

  30. Turner HE, Naqy Z, Esiri MM, Harris AL, Wass JA (2000) Role of matrix metalloproteinase 9 in pituitary tumor behavior. J Clin Endocrinol Metab 85:2931–2935

    Article  CAS  PubMed  Google Scholar 

  31. Li Y, Li K, Han X, Mao C, Zhang K, Zhao T, Zhao J (2015) The imbalance between TIMP3 and matrix-degrading enzymes plays an important role in intervertebral disc degeneration. Biochem Biophys Res Commun 469:507–514

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was partly supported by promotional funds for the Keirin Race of the Japan Keirin Association and the Jichi Medical University Graduate Student Research Award.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takashi Yashiro.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tofrizal, A., Fujiwara, K., Azuma, M. et al. Tissue inhibitors of metalloproteinase-expressing cells in human anterior pituitary and pituitary adenoma. Med Mol Morphol 50, 145–154 (2017). https://doi.org/10.1007/s00795-017-0155-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00795-017-0155-x

Keywords

Navigation